Jun 2024 $5 M No. 6 $2 to $10 million 28
Provisio Medical, Inc.: Raise no. 6, Jun 2024 × Investors in this round 28 investors had bought by the notice of Jul 3, 2024: 28 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $15 M offered; $10 M still to sell
Smallest investment taken $50,000
What was sold equity, debt, other: Units of Series B Debentures and Warrants Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $500,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice John J. Blake · Executive Officer Stephen Eric Ryan · Executive Officer, Director, Promoter Aurelio Eric Fernandez · Director Frank J. Del Rio · Director John J. McCallum · Director Michael J. Chobotov · Director Timothy Eric Lindenfelser · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On fees: “Broker may also receive warrant compensation equal to 1% (up to 3%) of the Gross Proceeds sold by said broker. Term of five years, cashless exercise option, convertible into common shares, and exercise price = $3.91 per share.”Signed by Stephen Eric Ryan, President. Source: SEC Form D, newest notice filed Jul 3, 2024. Read the notice at the SEC .
equity, debt SEC Apr 2023 $5 M No. 5 $2 to $10 million 19
Provisio Medical, Inc.: Raise no. 5, Apr 2023 × Investors in this round 19 investors had bought by the notice of Apr 7, 2023: 19 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $25 M offered; $20 M still to sell
Smallest investment taken $100,000
What was sold equity, other: Preferred Stock Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $115,500
Finders' fees none
Paid to its own people $500,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions and payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice John J. Blake · Executive Officer Stephen Eric Ryan · Executive Officer, Director, Promoter Aurelio Eric Fernandez · Director Frank J. Del Rio · Director John J. McCallum · Director Michael J. Chobotov · Director Timothy Eric Lindenfelser · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round LifeSci Capital (CRD 168404) · broker-dealer LifeSci Capital (CRD 168404) · New York, New York Sold in all US states Remarks in the notice On fees: “Broker also to receive warrant compensation = equity warrants equal to 1% of the Gross Proceeds sold by said broker. Term of five years, cashless exercise option, convertible into common shares, and exercise price = 125% of the price per share paid by in”Signed by Stephen Eric Ryan, President. Source: SEC Form D, newest notice filed Apr 7, 2023. Read the notice at the SEC .
equity SEC Nov 2022 $11 M No. 4 $10 to $50 million 53
Provisio Medical, Inc.: Raise no. 4, Nov 2022 × Investors in this round 53 investors had bought by the notice of Nov 25, 2022: 53 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $11 M of $30 M offered; $19 M still to sell
Smallest investment taken $100,000
What was sold equity, other: Preferred Stock Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $115,500
Finders' fees none
Paid to its own people $500,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions and payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice John J. Blake · Executive Officer Stephen Eric Ryan · Executive Officer, Director, Promoter Aurelio Eric Fernandez · Director Frank J. Del Rio · Director John J. McCallum · Director Michael J. Chobotov · Director Timothy Eric Lindenfelser · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round LifeSci Capital (CRD 168404) · broker-dealer LifeSci Capital (CRD 168404) · New York, New York Sold in all US states Remarks in the notice On fees: “Broker also to receive warrant compensation = equity warrants equal to 1% of the Gross Proceeds sold by said broker. Term of five years, cashless exercise option, convertible into common shares, and exercise price = 125% of the price per share paid by in”Signed by Stephen Eric Ryan, President. Source: SEC Form D, newest notice filed Nov 25, 2022. Read the notice at the SEC .
equity SEC Jan 2021 $4 M No. 3 $2 to $10 million 16
Provisio Medical, Inc.: Raise no. 3, Jan 2021 × Investors in this round 16 investors had bought by the notice of Jun 4, 2021: 16 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $4 M offered
Smallest investment taken $50,000
What was sold equity, other: Preferred Stock Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $400,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Stephen Eric Ryan · Executive Officer, Director, Promoter Aurelio Eric Fernandez · Director Frank J. Del Rio · Director George J. Quinoy · Director Timothy Eric Lindenfelser · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Stephen Eric Ryan, President. Source: SEC Form D and 1 amendment, newest notice filed Jun 4, 2021. Read the notice at the SEC .
equity SEC Aug 2019 $5 M No. 2 $2 to $10 million 24
Provisio Medical, Inc.: Raise no. 2, Aug 2019 × Investors in this round 24 investors had bought by the notice of Jul 23, 2020: 24 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $5 M offered
Smallest investment taken $50,000
What was sold equity, other: Preferred Stock Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $700,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Stephen Eric Ryan · Executive Officer, Director, Promoter Aurelio Eric Fernandez · Director George Eric Quinoy · Director Kenneth Eric McDonnell · Director Timothy Eric Lindenfelser · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Stephen Eric Ryan, President. Source: SEC Form D and 3 amendments, newest notice filed Jul 23, 2020. Read the notice at the SEC .
equity SEC Sep 2016 $1 M No. 1 Under $2 million 10
Provisio Medical, Inc.: Raise no. 1, Sep 2016 × Investors in this round 10 investors had bought by the notice of May 17, 2017: 10 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $1 M offered
Smallest investment taken $25,000
What was sold equity, other: Preferred Stock Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $175,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Stephen Eric Ryan · Executive Officer, Director, Promoter Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Stephen Eric Ryan, President. Source: SEC Form D, newest notice filed May 17, 2017. Read the notice at the SEC .
equity SEC